title: Definition of intervention points in prediabetes.
abstract: With respect to clinical phenotype and pathophysiology, prediabetes is akin to diabetes. Prediabetes is prevalent in the global population, and those affected are at high risk of progression to overt diabetes, and also at risk of cardiovascular disease (CVD). Progression to diabetes can occur because of worsening insulin resistance, β-cell dysfunction, or both, but the timecourse can be non-linear and, therefore, unpredictable. Intervention-by lifestyle modification, glucose-lowering drugs, or a combination-can postpone deterioration of glucose control, but effects of intervention are variable and can be transient. Furthermore, to what extent interventions can reduce cardiovascular risk is uncertain. Lifestyle intervention mainly hinges on weight loss; as such, risk of failure in the long-term is high, and implementation at the community level is difficult. The ideal candidate for intervention is an individual with prediabetes-identified by targeted screening-with many well documented cardiovascular risk factors, and who is highly motivated to initiate and maintain multifactorial risk-control using a personalised mix of lifestyle-adaptation and pharmacological treatment.
authors.affiliation: Department of Clinical and Experimental Medicine, University of Pisa School of Medicine, Pisa, Italy. Electronic address: ferrani@ifc.cnr.it.
authors.forename: Ele
authors.initials: E
authors.lastname: Ferrannini
mesh_terms: D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D003131:Combined Modality Therapy; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D018450:Disease Progression; D006293:Health Promotion; D006801:Humans; D008019:Life Style; D008403:Mass Screening; D008954:Models, Biological; D050177:Overweight / Q000503:physiopathology / Q000628:therapy; D011236:Prediabetic State / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D012307:Risk Factors; D015431:Weight Loss